Cargando…
Duration of isolation and precautions in immunocompromised patients with COVID-19
Autores principales: | Taramasso, L., Sepulcri, C., Mikulska, M., Magnasco, L., Lai, A., Bruzzone, B., Dentone, C., Bassetti, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Healthcare Infection Society. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898969/ https://www.ncbi.nlm.nih.gov/pubmed/33631234 http://dx.doi.org/10.1016/j.jhin.2021.02.014 |
Ejemplares similares
-
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19
por: Baldi, Federico, et al.
Publicado: (2023) -
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient—A Case Study
por: Sepulcri, Chiara, et al.
Publicado: (2021) -
Anesthesia for COVID-19 patients: protocol and precautions
por: Aissaoui, Ouissal, et al.
Publicado: (2020) -
Higher Mortality and Intensive Care Unit Admissions in COVID-19 Patients with Liver Enzyme Elevations
por: Taramasso, Lucia, et al.
Publicado: (2020) -
Air Travel in the Time of Covid-19 Pandemic: Precautions and Preventions
por: Brar, Rinnie, et al.
Publicado: (2022)